About
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 30 2026
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Mar 23 2026
Aurinia Announces Management Transition
Feb 26 2026
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
Feb 19 2026
Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026
Dec 16 2025
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors
Financials
Revenue
$283.06 M
Market Cap
$2.08 B
P/E Ratio
7.54
EPS
2.07
Translate